217 related articles for article (PubMed ID: 23796045)
1. The effect of sildenafil on evolving bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled pilot study.
König K; Barfield CP; Guy KJ; Drew SM; Andersen CC
J Matern Fetal Neonatal Med; 2014 Mar; 27(5):439-44. PubMed ID: 23796045
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?
Nyp M; Sandritter T; Poppinga N; Simon C; Truog WE
J Perinatol; 2012 Jan; 32(1):64-9. PubMed ID: 21941230
[TBL] [Abstract][Full Text] [Related]
3. The effect of sildenafil on retinopathy of prematurity in very preterm infants.
Fang AY; Guy KJ; König K
J Perinatol; 2013 Mar; 33(3):218-21. PubMed ID: 22766743
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial.
Abounahia FF; Abu-Jarir R; Abounahia MF; Al-Badriyeh D; Abushanab D; Abu-Ghalwa M; Mansour A; Kurdi B; Al-Rifai H
Clin Drug Investig; 2019 Nov; 39(11):1093-1107. PubMed ID: 31414269
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension.
Gürakan B; Kayiran P; Oztürk N; Kayiran SM; Dindar A
Pediatr Pulmonol; 2011 Jun; 46(6):617-20. PubMed ID: 21438177
[TBL] [Abstract][Full Text] [Related]
7. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
8. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study.
Baquero H; Soliz A; Neira F; Venegas ME; Sola A
Pediatrics; 2006 Apr; 117(4):1077-83. PubMed ID: 16585301
[TBL] [Abstract][Full Text] [Related]
9. Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health.
Khorana M; Yookaseam T; Layangool T; Kanjanapattanakul W; Paradeevisut H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S64-73. PubMed ID: 22043756
[TBL] [Abstract][Full Text] [Related]
10. Severe pulmonary arterial hypertension in a very premature baby with bronchopulmonary dysplasia: normalization with long-term sildenafil.
Caputo S; Furcolo G; Rabuano R; Basilicata AM; Pilla LM; De Simone A; Pasquariello B; Ciampi Q; Vetrano G; Villari B
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):704-6. PubMed ID: 19829144
[TBL] [Abstract][Full Text] [Related]
11. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia.
Wardle AJ; Wardle R; Luyt K; Tulloh R
Arch Dis Child; 2013 Aug; 98(8):613-7. PubMed ID: 23625986
[TBL] [Abstract][Full Text] [Related]
12. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil for pulmonary hypertension complicating bronchopulmonary dysplasia.
Bhatt-Mehta V; Donn SM
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):393-5. PubMed ID: 24866752
[TBL] [Abstract][Full Text] [Related]
14. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997.
Stoelhorst GM; Rijken M; Martens SE; Brand R; den Ouden AL; Wit JM; Veen S;
Pediatrics; 2005 Feb; 115(2):396-405. PubMed ID: 15689337
[TBL] [Abstract][Full Text] [Related]
15. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
[TBL] [Abstract][Full Text] [Related]
16. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Marr BL; Mettelman BB; Bode MM; Gross SJ
J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
[TBL] [Abstract][Full Text] [Related]
17. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil and Retinopathy of Prematurity in Preterm Infants with Bronchopulmonary Dysplasia.
Aboudi D; Swaminathan N; Brumberg H; Shi Q; Friedman D; Parvez B; Krishnan U
J Pediatr; 2018 Aug; 199():16-21. PubMed ID: 29753546
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
Ballard RA; Truog WE; Cnaan A; Martin RJ; Ballard PL; Merrill JD; Walsh MC; Durand DJ; Mayock DE; Eichenwald EC; Null DR; Hudak ML; Puri AR; Golombek SG; Courtney SE; Stewart DL; Welty SE; Phibbs RH; Hibbs AM; Luan X; Wadlinger SR; Asselin JM; Coburn CE;
N Engl J Med; 2006 Jul; 355(4):343-53. PubMed ID: 16870913
[TBL] [Abstract][Full Text] [Related]
20. Oral sildenafil for treatment of severe pulmonary hypertension in an infant.
Hon KL; Cheung KL; Siu KL; Leung TF; Yam MC; Fok TF; Ng PC
Biol Neonate; 2005; 88(2):109-12. PubMed ID: 15870496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
